| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |